Back

Myocardial redox state predicts 3-year mortality in patients undergoing cardiac surgery: the ox-HVF study

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Metabolism and redox mechanism in Cardiovascular Disease Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Christos Kotanidis

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

12 More presentations in this session

Presentation thumbnail
Inhibitory phosphorylation of RIP1 at Ser320 induces nuclear translocation of TFEB, leading to suppression of necroptosis in cardiomyocytes
Doctor K. Abe (Sapporo, JP)
Abstract Slides
Presentation thumbnail
Role of the nicotinamide riboside kinase 2 in NAD metabolism in the heart in basal and pathological condition
Doctor A. Karoui (Chatenay Malabry, FR)
Abstract
Presentation thumbnail
Role of autophagy in imatinib-induced cardiotoxicity
Associate Professor M. Kobara (Kyoto, JP)
Abstract Slides
Presentation thumbnail
Impact of the cardiac specific deletion of AMPKalpha2 on the contractile and metabolic phenotype of the heart in male and female mice
Miss L. Grimbert (Chatenay-Malabry, FR)
Abstract Slides
Presentation thumbnail
The impact of exercise training in combination with statin use on skeletal muscle mitochondrial oxidative phosphorylation and metabolomics in obese rats
Ms I. Urbaneck (Greifswald, DE)
Abstract

Access the full session

Session thumbnail
Poster Session 7 - Metabolism and redox mechanism in Cardiovascular Disease

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources